The Quality Lowdown: Rewarding Your Best Quality Critics
Executive Summary
Lupin hires former nemesis at FDA, how Baker exposed Hisun’s ‘full investigation,’ Cetylite’s many methods for overcoming OOS results, old school inspection-driven recalls at Vitae Enim Vitae Scientific and a critique of Catalent filling line’s non-deliberate response to the pandemic.
You may also be interested in...
Return Of Ductwork Cross-Contamination In Plants Flagged By US FDA Experts
Cleaning oversights are again allowing drug residues to collect in manufacturing equipment ductwork and contaminate drug product batches at sometimes dangerous levels, agency enforcement and compliance officials say. They share some ideas for getting such problems under control.
Lupin Insists It Will Rebuild Quality Reputation Following Latest FDA Action
Lupin says it is rebuilding its reputation for quality and compliance after the US FDA awarded VAI status to a manufacturing facility in Goa that was hit by a warning letter back in 2017.
Lupin’s Corporate Quality Oversight Questioned In FDA Warning Letter
Two-month inspection during pandemic highlighted cross-contamination risks and process validation shortfalls at New Jersey plant.